Genetic Basis of Cancer | Community Health

The genetic basis of cancer refers to the complex interplay of genetic mutations and alterations that contribute to the development and progression of cancer. With over 100 types of cancer, each with its unique genetic profile, understanding the genetic basis of cancer is crucial for developing effective treatments and prevention strategies. According to the World Health Organization (WHO), cancer is responsible for an estimated 9.6 million deaths in 2018, with the global cancer burden expected to rise to 27.5 million new cases by 2030. Research has shown that genetic mutations, such as those in the TP53 and BRCA1 genes, can significantly increase the risk of developing certain types of cancer. The genetic basis of cancer is a rapidly evolving field, with advances in genetic sequencing and editing technologies, such as CRISPR, offering new avenues for cancer treatment and prevention. For instance, a study published in the journal Nature found that CRISPR-based therapies can effectively target and eliminate cancer cells with specific genetic mutations.